Pilar Giraldo

Pilar Giraldo

UNVERIFIED PROFILE

Are you Pilar Giraldo?   Register this Author

Register author
Pilar Giraldo

Pilar Giraldo

Publications by authors named "Pilar Giraldo"

Are you Pilar Giraldo?   Register this Author

100Publications

3581Reads

8Profile Views

Muscle-tendon weakness contributes to chronic fatigue syndrome in Gaucher's disease.

J Orthop Surg Res 2019 Nov 21;14(1):383. Epub 2019 Nov 21.

Fundación Española Estudio y Tratamiento de la Enfermedad de Gaucher y Otras Lisosomales (FEETEG), Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13018-019-1452-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873505PMC
November 2019

Evaluation of two approaches to lysosomal acid lipase deficiency patient identification: An observational retrospective study.

Atherosclerosis 2019 06 18;285:49-54. Epub 2019 Mar 18.

Instituto de Investigación Sanitaria Aragón (IIS Aragón), GIIS-012, Zaragoza, 50009, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), CB/06/07/1036, Instituto de Salud Carlos III (ISCIII), Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain; Fundación Española para el Estudio y Terapéutica de la Enfermedad de Gaucher y Otras Lisosomales (FEETEG), Zaragoza, 50008, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2019.03.013DOI Listing
June 2019

Web-Based Bioinformatics Predictors: Recommendations to Assess Lysosomal Cholesterol Trafficking Diseases-Related Genes.

Methods Inf Med 2019 06 5;58(1):50-59. Epub 2019 Jul 5.

Instituto de Investigación Sanitaria Aragón (IIS Aragón), Unidad de Investigación Traslacional (GIIS012), Hospital Universitario Miguel Servet, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1692463DOI Listing
June 2019

The erythrocyte osmotic resistance test as screening tool for cholesterol-related lysosomal storage diseases.

Clin Chim Acta 2018 May 13;480:161-165. Epub 2018 Feb 13.

Instituto de Investigación Sanitaria Aragón (IIS Aragón) GIIS-012, Unidad de Investigación Traslacional, Hospital Universitario Miguel Servet, Zaragoza 50009, Spain; Fundación para el Estudio y la Terapéutica de la Enfermedad de Gaucher y Otras Lisosomales (FEETEG), Zaragoza 50009, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) U-752, Zaragoza 50009, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2018.02.010DOI Listing
May 2018

The utility of magnetic resonance imaging for bone involvement in Gaucher disease. Assessing more than bone crises.

Blood Cells Mol Dis 2018 02 21;68:126-134. Epub 2016 Oct 21.

Translational Research Unit, Aragon Health Research Institute (IIS-A), Zaragoza, Spain; CIBER de Enfermedades Raras, CIBERER, Zaragoza, Spain; Fundación Española para el Estudio y Terapéutica de la Enfermedad de Gaucher (FEETEG), Zaragoza, Spain. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10799796163021
Publisher Site
http://dx.doi.org/10.1016/j.bcmd.2016.10.004DOI Listing
February 2018

Home infusion of intravenous velaglucerase alfa: Experience from pooled clinical studies in 104 patients with type 1 Gaucher disease.

Mol Genet Metab 2017 Jan - Feb;120(1-2):111-115. Epub 2016 Aug 23.

Shaare Zedek Medical Center and Hadassah Medical School, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymgme.2016.08.005DOI Listing
August 2017

Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe.

Eur J Intern Med 2017 Jan 10;37:25-32. Epub 2016 Aug 10.

Department of Medicine, University of Cambridge, Box 157, Level 5, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejim.2016.07.011DOI Listing
January 2017

Inhibition of Intermediate-Conductance Calcium-Activated K Channel (KCa3.1) and Fibroblast Mitogenesis by α-Linolenic Acid and Alterations of Channel Expression in the Lysosomal Storage Disorders, Fabry Disease, and Niemann Pick C.

Front Physiol 2017 31;8:39. Epub 2017 Jan 31.

Instituto de Investigación Sanitaria AragónZaragoza, Spain; Aragón Institute of Health SciencesZaragoza, Spain; Centro de Investigación Biomédica en Red de Enfermedades RarasZaragoza, Spain; Aragón Agency for Research and DevelopmentZaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphys.2017.00039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5281581PMC
January 2017

Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.

N Engl J Med 2016 Aug;375(6):545-55

From the Division of Medical Genetics, University of Versailles, Paris-Saclay University, Versailles, and Assistance Publique-Hôpitaux de Paris, Paris - both in France (D.P.G.); the Department of Academic Haematology, Royal Free and University College Medical School, London (D.A.H.), Salford Royal NHS Foundation Trust, Salford (A.J.), and University of Sunderland, Sunderland (S.W.) - all in the United Kingdom; the Department of Nephrology, Royal Melbourne Hospital, Parkville, VIC (K. Nicholls), and the Metabolic Clinic, Women's and Children's Hospital, Adelaide, SA (D.B.) - both in Australia; the Clinical Research Division, Hôpital du Sacré-Coeur, Montreal (D.G.B.); Medical Genetics Service, Clinic Hospital of Porto Alegre, Porto Alegre (R.G.), and Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo-Ribeirão Preto, Ribeirão Preto (C.M.L.) - both in Brazil; the Departments of Human Genetics (W.R.W., S.P.S.) and Ophthalmology (S.P.S.), Emory University School of Medicine, Atlanta; the Dermatology Unit, University of Parma, Parma, Italy (C.F.); the Faculty of Medicine, Department and Laboratory of Pediatric Metabolic Disorders, Gazi University, Ankara, Turkey (F.E.); the Department of Pediatrics, Hospital Alemán, Buenos Aires (H.A.); the Department of Medical Endocrinology, Rigshospital, Copenhagen University Hospital, Copenhagen (U.F.-R.); Infusion Associates, Grand Rapids, MI (K. Nedd); the Faculty of Medicine, Kasr El Ainy Hospital, Cairo (U.S.E.D.); New York Presbyterian Hospital, New York (M.B.); the Division of Genetics, Ann & Robert H. Lurie Children's Hospital of Chicago, and Northwestern University Feinberg School of Medicine, Chicago (J. Charrow); the Department of Urology, University of Kansas Medical Center, Kansas City (M.D., A.T.); Children's Hospital of Pittsburgh, Pittsburgh (D.F.); Hospital Miguel Servet, Zaragoza (P.G.), and Fundacio Puigvert, Universidad Autónoma de Barcelona, Barcelona (R.T.) - both in Spain; O & O Alpa

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1510198DOI Listing
August 2016

The influence of genetic variability and proinflammatory status on the development of bone disease in patients with Gaucher disease.

PLoS One 2015 15;10(5):e0126153. Epub 2015 May 15.

Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Zaragoza, Spain; Translational Research Unit, Miguel Servet University Hospital, Zaragoza, Spain; Spanish Gaucher Disease Foundation (FEETEG), Zaragoza, Spain; Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126153PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433334PMC
April 2016

Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disorders.

Mol Genet Metab 2016 Feb 23;117(2):186-93. Epub 2015 Dec 23.

Department of Medical Biochemistry, Academic Medical Center, 1105, AZ, Amsterdam, The Netherlands; Department of Medical Biochemistry, Leiden Institute of Chemistry, Leiden University, 2333, CC, Leiden, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymgme.2015.12.006DOI Listing
February 2016

Patients with type 1 Gaucher disease in Spain: A cross-sectional evaluation of health status.

Blood Cells Mol Dis 2016 Jan 9;56(1):23-30. Epub 2015 Oct 9.

Department of Hematology, 12 de Octubre Hospital, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2015.10.001DOI Listing
January 2016

Patients Older Than 65 Years With Non-Hodgkin Lymphoma Are Suitable for Treatment With (90)Yttrium-Ibritumumab Tiuxetan: A Single-Institution Experience.

Clin Lymphoma Myeloma Leuk 2015 Aug 5;15(8):464-71. Epub 2015 Mar 5.

Translational Research Unit, Miguel Servet University Hospital-Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain; Centro de Investigación Biomédica en Red (CIBERER) Instituto de Salud Carlos III, Zaragoza, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.02.025DOI Listing
August 2015

Safety and efficacy results of switch from imiglucerase to velaglucerase alfa treatment in patients with type 1 Gaucher disease.

Am J Hematol 2015 Jul;90(7):592-7

Gaucher Clinic, Shaare Zedek Medical Center, affiliated with the Hebrew University-Hadassah Medical School, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24007DOI Listing
July 2015

Association of ferritin elevation and metabolic syndrome in males. Results from the Aragon Workers' Health Study (AWHS).

J Clin Endocrinol Metab 2015 May 19;100(5):2081-9. Epub 2015 Feb 19.

Instituto Aragonés de Ciencias de la Salud (M.Led., M.Leo., P.G., M.P., F.C., J.A.C.), 50009 Zaragoza, Spain; Department of Epidemiogy, Atherothrombosis and Imaging (Y.H.-R., J.M.O., M.La), Spanish National Center for Cardiovascular Research, 28029 Madrid, Spain; CIBER de enfermedades Raras CIBERER, 50009 Zaragoza, Spain (P.G.); Departments of Epidemiology and Medicine (E.G.), and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205; Department of Preventive Medicine and Public Health (M.La), School of Medicine, Universidad Autonoma de Madrid, 28029 Madrid, Spain; and Department of Epidemiology (M.La), St. Louis University, St. Louis, Missouri 63104.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2014-4409DOI Listing
May 2015

Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review.

Eur J Haematol 2014 Mar 10;92(3):181-8. Epub 2014 Jan 10.

Hospital Universitario de la Princesa, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12239DOI Listing
March 2014

Characterization of variants in the glucosylceramide synthase gene and their association with type 1 Gaucher disease severity.

Hum Mutat 2013 Oct 13;34(10):1396-403. Epub 2013 Aug 13.

Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Valencia, Spain; Unidad de Investigación Traslacional, Hospital Universitario Miguel Servet, Zaragoza, Spain; Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.22381DOI Listing
October 2013

Miglustat therapy in type 1 Gaucher disease: clinical and safety outcomes in a multicenter retrospective cohort study.

Blood Cells Mol Dis 2013 Aug 14;51(2):116-24. Epub 2013 May 14.

Hematology Division, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2013.04.005DOI Listing
August 2013

Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.

N Engl J Med 2013 Aug;369(5):438-47

Hospital Universitario de Salamanca, Instituto de Biología Molecular y Celular del Cáncer, Universidad de Salamanca-Consejo Superior de Investigaciones Científicas, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1300439DOI Listing
August 2013

A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma.

Br J Haematol 2013 Mar 7;160(5):649-59. Epub 2013 Jan 7.

Department of Cellular Biotechnology and Haematology, Sapienza University of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12198DOI Listing
March 2013

The cognitive profile of type 1 Gaucher disease patients.

J Inherit Metab Dis 2012 Nov 21;35(6):1093-9. Epub 2012 Feb 21.

Department of Internal Medicine, Academic Medical Center, F5-169, Box 22700, 1100 DE, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10545-012-9460-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470680PMC
November 2012

Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula.

Orphanet J Rare Dis 2012 Mar 19;7:17. Epub 2012 Mar 19.

Centro de Investigación Biomédica en Red de Enfermedades Raras, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1750-1172-7-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349595PMC
March 2012

Gastrointestinal disturbances and their management in miglustat-treated patients.

J Inherit Metab Dis 2011 Oct 21;34(5):991-1001. Epub 2011 Jul 21.

Reference Centre for Lysosomal Diseases, Beaujon Hospital, Clichy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10545-011-9368-7DOI Listing
October 2011

[Rare diseases. Introduction].

Authors:
Pilar Giraldo

Med Clin (Barc) 2011 Sep;137 Suppl 1:1-2

Grupo de Estudio de Enfermedad de Gaucher y Neoplasias Hematológicas, Servicio de Hematología, Hospital Universitario Miguel Servet; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER-U752), Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0025-7753(11)70008-2DOI Listing
September 2011

[Safety of use of velaglucerase in 2 patients with type 1 Gaucher's disease].

Med Clin (Barc) 2011 Sep;137 Suppl 1:39-42

Atención Primaria Delicias Norte, Fundación Española para el Estudio y Tratamiento de la Enfermedad de Gaucher, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0025-7753(11)70015-XDOI Listing
September 2011

[Therapeutic targets in Gaucher's disease].

Med Clin (Barc) 2011 Sep;137 Suppl 1:46-9

Grupo de Estudio de Enfermedad de Gaucher y Neoplasias Hematológicas, Servicio de Hematología, Hospital Universitario Miguel Servet, Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0025-7753(11)70017-3DOI Listing
September 2011

[Current treatment for Gaucher's disease and new prospects].

Med Clin (Barc) 2011 Sep;137 Suppl 1:50-4

Grupo de Estudio de Enfermedad de Gaucher y Neoplasias Hematológicas, Servicio de Hematología, Hospital Universitario Miguel Servet, Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0025-7753(11)70018-5DOI Listing
September 2011

[Guidelines for type 1 Gaucher's disease].

Authors:
Pilar Giraldo

Med Clin (Barc) 2011 Sep;137 Suppl 1:55-60

Grupo de Estudio de Enfermedad de Gaucher y Neoplasias Hematológicas, Servicio de Hematología, Hospital Universitario Miguel Servet, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0025-7753(11)70019-7DOI Listing
September 2011

Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis.

Metabolism 2011 Jun 16;60(6):830-4. Epub 2010 Sep 16.

Unidad de Lípidos and Laboratorio de Investigacion Molecular, Hospital Universitario Miguel Servet, Instituto Aragones de Ciencias de la Salud (I + CS), 50009 Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.metabol.2010.07.035DOI Listing
June 2011

Neurological manifestations in patients with Gaucher disease and their relatives, it is just a coincidence?

J Inherit Metab Dis 2011 Jun 8;34(3):781-7. Epub 2011 Mar 8.

Hematology Department, Miguel Servet University Hospital, Pº Isabel La Católica 1-3, 50009 Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10545-011-9298-4DOI Listing
June 2011

Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study.

Brain 2010 Oct 7;133(10):2909-19. Epub 2010 Aug 7.

Department of Neurology, Academic Medical Centre, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awq198DOI Listing
October 2010

Population-based incidence of childhood leukaemias and lymphomas in Spain (1993-2002).

Eur J Cancer Prev 2010 Jul;19(4):247-55

Department of Health, University of Girona, Girona Cancer Registry-Catalan Cancer Plan, Girona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CEJ.0b013e328339e2f3DOI Listing
July 2010

Goal-oriented therapy with miglustat in Gaucher disease.

Curr Med Res Opin 2009 Jan;25(1):23-37

Neurology and Pediatrics, New York University School of Medicine, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007990802576518DOI Listing
January 2009

Gaucher disease: report of de novo GBA mutation in a Spanish family.

Blood Cells Mol Dis 2008 May-Jun;40(3):444-5. Epub 2008 Mar 3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2008.01.005DOI Listing
August 2008

[Neurological manifestations in patients with Gaucher disease and in their relatives].

Med Clin (Barc) 2008 Jul;131(5):175-9

Servicio de Hematología, Hospital Universitario Miguel Servet, Zaragoza, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1157/13124962DOI Listing
July 2008

Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States.

Eur J Cancer 2008 Mar 31;44(4):579-87. Epub 2008 Jan 31.

Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, I-20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2007.12.016DOI Listing
March 2008

[Lysosomal storage disorders. Is the natural history of the disease changing?].

Med Clin (Barc) 2008 Mar;130(7):259-60

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1157/13116550DOI Listing
March 2008

Mutation analysis and genotype/phenotype relationships of Gaucher disease patients in Spain.

J Hum Genet 2007 11;52(5):391-6. Epub 2007 Apr 11.

Departamento de Bioquímica y Biología Molecular y Celular, Facultad Ciencias, Universidad de Zaragoza, Plaza San Francisco s/n, 50009, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10038-007-0135
Web Search
http://www.nature.com/doifinder/10.1007/s10038-007-0135-4
Publisher Site
http://dx.doi.org/10.1007/s10038-007-0135-4DOI Listing
August 2007

Neurologic improvement in a type 3 Gaucher disease patient treated with imiglucerase/miglustat combination.

Epilepsia 2007 Jul 13;48(7):1406-8. Epub 2007 Apr 13.

Department of Neurology, Miguel Servet University Hospital, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1528-1167.2007.01074.xDOI Listing
July 2007